Sci-Tech News Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Network.

Press releases published on August 28, 2026

Relanto Launches R-TokenomIQ™: A Unified Platform for Enterprise AI Economics
Lisa Eaton Therapy & Coaching Shares Therapist’s Perspective on AI and Emotional Support
TibaRay’s Cancer Technology: Protected by 21 Issued and Pending Patents
Top Stainless Steel Manufacturer Strengthens Its Position in the Global Steel Market
Sample Preparation Market Intelligence Report Covers Trends, Segments And Regional Growth
Sedimentation Centrifuge Market Insights Highlight Segment Expansion And Market Leadership
Self-Expanding Stents Market Outlook Highlights Strategic Opportunities Across The Industry
Humanity's Team Sees a Common Thread in Nepal Floods, AI Water Strain and Job Risk
Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome
BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals
Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million
Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results
CDT Validates Enhanced Solid-Form Properties Within Its IP Portfolio
STARCARES Completes Basketball Court Revamp in the Philippines, Benefiting Nearly 20,000 People
Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
Micware Group Reorganization Finalized
OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026
OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech News Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.